Format

Send to

Choose Destination
Influenza Other Respir Viruses. 2015 May;9(3):151-4. doi: 10.1111/irv.12303. Epub 2015 Feb 27.

Detection of influenza A and B with the Alere ™ i Influenza A & B: a novel isothermal nucleic acid amplification assay.

Author information

1
Centre for Infectious Diseases and Microbiology Laboratory Services, Institute for Clinical Pathology and Medical Research, Westmead Hospital, Westmead, NSW, Australia; Westmead Clinical School, University of Sydney, Westmead Hospital, Westmead, NSW, Australia.

Abstract

BACKGROUND:

Rapid influenza diagnostic tests (RIDTs) have an important role in clinical decision-making; however, the performances of currently available assays vary widely.

OBJECTIVES:

We evaluated the performance of the Alere(™) i Influenza A&B (Alere(™) iNAT), a rapid isothermal nucleic acid amplification assay that has recently received FDA clearance, for the detection of influenza A and B viruses during the Australian influenza season of 2013. Results were compared to two other RIDTs tested in parallel; Quidel Sofia(®) Influenza A+B fluorescent immunoassay (FIA) and Alere(™) BinaxNOW(®) Influenza A & B immunochromatographic (ICT) assay.

METHODS:

A total of 202 paired nasopharyngeal swabs collected from patients ≥ 16 years old with an influenza-like illness (ILI) were eluted in 2 ml of universal transport medium (UTM) that was used to perform all three RIDTs in parallel. Reverse-transcription polymerase chain reaction (RT-PCR) was used as the reference standard.

RESULTS:

Compared to RT-PCR, Alere(™) iNAT detected 77.8% influenza A positive samples versus 71.4% and 44.4% for the Quidel Sofia(®) Influenza A+B FIA and BinaxNOW(®) Influenza A & B ICT assay, respectively. For influenza B, Alere(™) iNAT detected 75% of those positive by RT-PCR, versus 33.3% and 25.0% for Sofia(®) and BinaxNOW(®), respectively. The specificity of Alere(™) iNAT was 100% for influenza A and 99% for influenza B.

CONCLUSIONS:

Alere(™) i Influenza A&B is a promising new rapid influenza diagnostic assay with potential point-of-care applications.

KEYWORDS:

Influenza; isothermal nucleic acid amplification; rapid diagnostic test(s); sensitivity; specificity

PMID:
25728758
PMCID:
PMC4415699
DOI:
10.1111/irv.12303
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Wiley Icon for PubMed Central
Loading ...
Support Center